PHOENIX, Feb. 2, 2026 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions for managing rodent populations, is pleased to announce that Evolve® has been approved ...
PHOENIX, March 12, 2025 /PRNewswire/ -- SenesTech, Inc. (SNES) (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in fertility control solutions for managing rodent populations, today announced ...
Good afternoon, and welcome to the SenesTech Second Quarter Fiscal Year 2025 Financial Results Conference Call. [Operator Instructions] Please note that this event is being recorded. I would now like ...
Earnings call SenesTech reported FY2025 revenue up 20% to $2.2M (would have been ~30% excluding a one-time Amazon transition impact), with gross margin rising to 62.5%. E-commerce now exceeds half of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results